Paper23948295
IL-11: a prominent pro-tumorigenic member of the IL-6 family.
Grivennikov SI. Cancer Cell, 2013. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. IL-11: a prominent pro-tumorigenic member of the IL-6 family. Papers, record 23948295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23948295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Comment
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Gastrointestinal Neoplasms | Major topic |
| Interleukin-11 | Major topic |
| Interleukin-6 | Major topic |
| Animals | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R00 DK088589 | NIDDK NIH HHS | United States | R00DK088589 | PubMed and NIH |
| R00DK088589 | NIDDK NIH HHS | United States | R00DK088589 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 23948300 | Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. | https://conductscience.org/library/papers/23948300 |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15485627 | TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. | Immunity | 2004 | https://conductscience.org/library/papers/15485627 | PubMed |
| 2 | 23696660 | Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23696660 | PubMed |
| 3 | 19851315 | STATs in cancer inflammation and immunity: a leading role for STAT3. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19851315 | PubMed |
| 4 | 23075849 | IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. | Nature | 2012 | https://conductscience.org/library/papers/23075849 | PubMed |
| 5 | 19185845 | IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19185845 | PubMed |
| 6 | 18431520 | STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18431520 | PubMed |
| 7 | 23153532 | Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. | Cancer Cell | 2012 | https://conductscience.org/library/papers/23153532 | PubMed |
| 8 | 23948300 | Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. | Cancer Cell | 2013 | https://conductscience.org/library/papers/23948300 | PubMed |
| 9 | 23321674 | mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23321674 | PubMed |
| 10 | 19185844 | gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19185844 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42798813 | Multifaceted roles of chemokines in gastric cancer: From tumor microenvironment modulation to therapeutic targeting (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42798813 | PubMed |
| 40040705 | Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/40040705 | PubMed |
| 39199587 | Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199587 | PubMed |
| 38248304 | Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and Invasion. | Brain Sci | 2024 | https://conductscience.org/library/papers/38248304 | PubMed |
| 37891977 | Tumor Microbial Communities and Thyroid Cancer Development-The Protective Role of Antioxidant Nutrients: Application Strategies and Future Directions. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37891977 | PubMed |
| 37659081 | AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages. | Cell Rep | 2023 | https://conductscience.org/library/papers/37659081 | PubMed |
| 37176567 | Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring. | J Clin Med | 2023 | https://conductscience.org/library/papers/37176567 | PubMed |
| 36986390 | Role of Gut Microbiota in Breast Cancer and Drug Resistance. | Pathogens | 2023 | https://conductscience.org/library/papers/36986390 | PubMed |
| 36611932 | The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies. | Cells | 2022 | https://conductscience.org/library/papers/36611932 | PubMed |
| 35096847 | Paracrine Behaviors Arbitrate Parasite-Like Interactions Between Tumor Subclones. | Front Ecol Evol | 2021 | https://conductscience.org/library/papers/35096847 | PubMed |
| 34083781 | Interleukins in cancer: from biology to therapy. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/34083781 | PubMed |
| 34079226 | Clinical Application of Cytokines in Cancer Immunotherapy. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34079226 | PubMed |
| 33604548 | Cytokines frequently implicated in myeloproliferative neoplasms. | Cytokine X | 2019 | https://conductscience.org/library/papers/33604548 | PubMed |
| 32995898 | [The microbiome in head and neck tumors-initial findings and outlook]. | HNO | 2020 | https://conductscience.org/library/papers/32995898 | PubMed |
| 32935263 | From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? | Rev Endocr Metab Disord | 2021 | https://conductscience.org/library/papers/32935263 | PubMed |
| 31864417 | Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection. | Vet Res | 2019 | https://conductscience.org/library/papers/31864417 | PubMed |
| 31686851 | Contribution of interaction between genetic variants of interleukin-11 and Helicobacter pylori infection to the susceptibility of gastric cancer. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31686851 | PubMed |
| 29100303 | KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/29100303 | PubMed |
| 28960674 | Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts. | Cancer Sci | 2017 | https://conductscience.org/library/papers/28960674 | PubMed |
| 28714957 | IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model. | Oncogene | 2017 | https://conductscience.org/library/papers/28714957 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2L11 | 10018 | PubTator's text mining | https://conductscience.org/library/genes/10018 | NCBI Gene |
| IL11 | 3589 | PubTator's text mining | https://conductscience.org/library/genes/3589 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| IL6ST | 3572 | PubTator's text mining | https://conductscience.org/library/genes/3572 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23948295
GET https://conductscience.org/api/papers/v1/23948295/cited_by?page=2